We advise on the suitability of new technologies and the evidence required to support their commercial uptake.
We broker collaborations between industry and clinical practice to test new technologies in community settings.
Our public contributors help steer and govern our work to ensure it is relevant to patients and carers.
Research and resources
29 September 2022
The NIHR is comitted to ensuring that equality, diversity and inclusion (EDI) is embedded in everything it does. Launching today (28th September) the EDI it an important step in realising this commitment.
Three out of four people with heart failure could be diagnosed sooner, potentially improving quality of life and reducing costs to the healthcare system.
30 November 2021
Researchers from the University of Oxford have today reported that only 1 in 4 people diagnosed with heart failure received a simple, recommended blood test that could have resulted in an earlier diagnosis at a more treatable stage.
Register for our newsletter
Get details on the latest news, opportunities and upcoming events with our quarterly email bulletin. You may also register for our public newsletter, produced in partnership with the University of Oxford and the NIHR CLAHRC Oxford.
Join our LinkedIn Group
Join the In Vitro Diagnostics in Primary Care LinkedIn Group and share your own news and opportunities with clinicians, researchers, industry representatives and healthcare delivery professionals.